7-28626150-T-C
Variant summary
The NM_182898.4(CREB5):c.464+55613T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene CREB5 is a known oncogene (CancerMine: 2 oncogene citations). The variant allele was found at a cumulative frequency of 0.23 (AC=35,000) in the gnomAD database across 152,152 control chromosomes, including 4,218 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.256. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_182898.4 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_benign. The variant received -4 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| B1High frequency in general population | GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.256 — exceeds 1% threshold (B1 applied) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_182898.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CREB5 | MANE Select | c.464+55613T>C | intron | Intron 5 of 10 | Prot: NP_878901.2 UniProt: | |
CREB5 | c.443+55613T>C | intron | Intron 5 of 10 | Prot: NP_004895.2 UniProt: | ||
CREB5 | c.365+55613T>C | intron | Intron 4 of 9 | Prot: NP_878902.2 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CREB5 | TSL:1MANE Select | c.464+55613T>C | intron | Intron 5 of 10 | Prot: ENSP00000350359.2 UniProt: | |
CREB5 | TSL:1 | c.443+55613T>C | intron | Intron 5 of 10 | Prot: ENSP00000379594.2 UniProt: | |
CREB5 | TSL:1 | c.365+55613T>C | intron | Intron 4 of 9 | Prot: ENSP00000379593.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | AF: 0.230 | AC:34971 | Hom:4215 | AN:152034 | Cov:32 |
GnomAD4 genome | AF: 0.230 | AC:35000 | Hom:4218 | AN:152152 | Cov:32 |
TOPMed (Bravo) | AF: 0.226 | AC:59830 | Hom:6968 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.235 | AC:61698 | Hom:7646 | AN:262180 | |
Local & regional cohorts 10 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.211 | AC:493 | Hom:50 | AN:2336 | |
ChinaMAP Phase 1 | AF: 0.122 | ||||
Denmark Genome | AF: 0.217 | AC:65 | AN:300 | ||
GenomeAsia100K | AF: 0.179 | AC:620 | AN:3476 | ||
Korea4K (4,157 Koreans) | AF: 0.0890 | AC:644 | AN:7224 | ||
Qatari Genome | AF: 0.204 | AC:36 | AN:176 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.0870 | AC:10672 | Hom:470 | AN:122686 | |
Turkish Variome | AF: 0.180 | AC:279 | Hom:32 | AN:1546 | |
UK10K | AF: 0.258 | AC:1953 | AN:7562 | ||
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.119 | AC:1070 | Hom:73 | AN:8960 | |
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Benign | 1.8 | |
BayesDel_noAF | Benign | -0.84 | |
CADD | Benign | 5.0 | |
DANN | Benign | 0.57 | |
GPN-Star LLR | N/A | -1.3 | |
GPN-Star score | N/A | 1.3 | |
Mutation Taster | N/A | 100/0 | polymorphism (auto) |
PhyloP100 | Benign | 0.19 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.